Search company, investor...

Stage

Seed | Alive

Total Raised

$1.54M

Last Raised

$1.54M | 3 yrs ago

About Xishine

Xishine is an artificial intelligence medical robot developer.

Headquarters Location

Shanghai, Shanghai,

China

Loading...

Loading...

Expert Collections containing Xishine

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Xishine is included in 3 Expert Collections, including Robotics.

R

Robotics

1,974 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.

A

Artificial Intelligence

10,958 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health

10,585 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Xishine Frequently Asked Questions (FAQ)

  • Where is Xishine's headquarters?

    Xishine's headquarters is located at Shanghai.

  • What is Xishine's latest funding round?

    Xishine's latest funding round is Seed.

  • How much did Xishine raise?

    Xishine raised a total of $1.54M.

  • Who are the investors of Xishine?

    Investors of Xishine include Jiuhetang Group and Xiamen PuDao Technology.

Loading...

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.